Physician profile
Christopher P Kovach
NPI 1396134243
$8,461.75
in general payments reported to CMS, 2019-2025
24 companies · $3,667 in 2025
The $3,667 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.49 · 2020: $420 · 2021: $50.43 · 2022: $545 · 2023: $1,245 · 2024: $2,480 · 2025: $3,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,596 · Travel and Lodging: $2,080 · Consulting Fee: $600 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,595.75 |
| Travel and Lodging | $2,079.87 |
| Consulting Fee | $600.00 |
| Education | $116.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,305.45 | 2023-2025 | Onyx Frontier, Symplicity G3, Telescope |
| Philips North America LLC | $1,597.76 | 2025 | Igt Devices Undivided, Labosys, IV Other |
| Boston Scientific Corporation | $732.89 | 2019-2025 | General - Vascular Intervention, Varithena Administration Pack, Seismiq Prime Catheter_pi |
| Angiodynamics, INC. | $679.91 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $563.32 | 2020-2025 | Esprit, Diamondback Peripheral, Supera |
| Abiomed | $337.87 | 2024-2025 | Impella |
| Shockwave Medical, INC | $255.28 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $240.33 | 2022-2023 | Diamondback Coronary |
| Pfizer INC. | $218.01 | 2024-2025 | |
| Asahi Intecc USA, INC. | $197.77 | 2025 | Asahi Peripheral Vascular Wires |
| Astellas Pharma US INC | $184.94 | 2020 | |
| Biotronik INC. | $170.67 | 2022 | |
| Cook Medical LLC | $165.34 | 2023-2025 | Zilver Ptx, Zenith Alpha |
| Cagent Vascular INC | $155.80 | 2023 | Serrantor |
| W. L. Gore & Associates, INC. | $123.42 | 2025 | Gore Cardioform Septal Occluder |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $116.36 | 2025 | |
| Amgen INC. | $89.73 | 2023-2025 | Repatha, Repatha |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Cordis US Corp. | $75.81 | 2023 | Radial 360 |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $42.43 | 2025 | Camzyos |
| Inspire Medical Systems, INC. | $31.61 | 2025 | Inspire |
| Sirtex Medical INC | $26.77 | 2025 | Sir-Spheres Microspheres |
| Recor Medical INC | $3.10 | 2024 | Paradise Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kovach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.